Coronavirus News Essentials

Europe - Coronavirus

Coronavirus in Europe Essentials publishes only the best news and links related to the Covid-19 virus in Europe, carefully hand-picked and curated by top experts.

Top news of the week: 09.11.2021.

Vaccination
BBC
Generic drug
Getty Images
Pharmacology
Health care

Coronavirus

@NIH shared
On Nov 4, 2021
RT @HHSGov: Parents and Caregivers: @CDCgov recommends that all children ages 5 and up get vaccinated against #COVID19. Vaccination is an important tool to help stop this pandemic. Get answers to your questions about COVID-19 vaccination for kids: https://t.co/ExR6ui5bDP. https://t.co/oMLLs7aGfi
Open
COVID-19 Vaccines for Children and Teens

COVID-19 Vaccines for Children and Teens

CDC recommends everyone 5 years and older get a COVID-19 vaccination.

@UKHSA shared
On Nov 4, 2021
RT @DHSCgovuk: BREAKING NEWS: A #COVID19 antiviral that can be taken at home has been approved for use across the UK by @MHRAgovuk Molnupiravir will soon be offered to patients in a national study to help protect those most at risk from the virus over the winter. More: https://t.co/YtZaaBJrw8 https://t.co/J5g8cCC6mL
Open
First oral antiviral for COVID-19, Lagevrio (molnupiravir), approved by MHRA

First oral antiviral for COVID-19, Lagevrio (molnupiravir), approved by MHRA

The antiviral was found to be safe and effective following a stringent review of the available evidence.

@bbchealth shared
On Nov 2, 2021
Covid-19: Sage scientist Sir Jeremy Farrar steps down from role https://t.co/xYdNamUEor
Open
Covid-19: Sage scientist Sir Jeremy Farrar steps down from role

Covid-19: Sage scientist Sir Jeremy Farrar steps down from role

He says levels of Covid transmission in the UK are "concerning" as he leaves the advisory group.

@cnnbrk shared
On Nov 5, 2021
Pfizer says its experimental pill designed to fight Covid-19 reduced the risk of hospitalization and death for high-risk patients by about 89% https://t.co/0g59naHpY4
Open
Pfizer says its experimental pill reduces risk of hospitalization, death from Covid-19

Pfizer says its experimental pill reduces risk of hospitalization, death from Covid-19

Drugmaker Pfizer said Friday its experimental pill designed to fight coronavirus reduced the risk of hospitalization and death for high-risk patients taking part in a trial of the drug.

@bbchealth shared
On Nov 7, 2021
Covid-19: Get booster to enjoy Christmas, and court blocks Biden's jab plan https://t.co/wShEvuYRRP
Open
Covid-19: Get booster to enjoy Christmas, and court blocks Biden's jab plan

Covid-19: Get booster to enjoy Christmas, and court blocks Biden's jab plan

Five things you need to know about the coronavirus pandemic this Sunday morning.

@TheEconomist shared
On Nov 4, 2021
RT @natashaloder: How Merck made plans to make sure its antiviral covid-19 drug molnupiravir was available on the four corners of the earth soon after launch. If it succeeds the speed and global breadth of this drug launch will be without precedent in history. https://t.co/WXMLa9daqC
Open
An effective new drug to treat covid-19 emerges from Merck

An effective new drug to treat covid-19 emerges from Merck

It hopes to make the drug available in poor countries as well as rich ones

@bbchealth shared
On Nov 5, 2021
Covid-19: Pfizer's antiviral pill and face masks behaviour study https://t.co/LaMATaPtFY
Open
Covid-19: Pfizer's antiviral pill and face masks behaviour study

Covid-19: Pfizer's antiviral pill and face masks behaviour study

Five things you need to know about the coronavirus pandemic this Friday evening.

@bmj_latest shared
On Nov 4, 2021
The UK’s medicines regulator has issued temporary authorisation of the antiviral drug molnupiravir for the treatment of mild to moderate covid-19 in adults with at least one risk factor for severe illness https://t.co/noWzVZYB8Q @emahase_ reports
Open
Covid-19: UK becomes first country to authorise antiviral molnupiravir

Covid-19: UK becomes first country to authorise antiviral molnupiravir

The UK’s medicines regulator has issued temporary authorisation of the antiviral drug molnupiravir for the treatment of mild to moderate covid-19 in adults with at least one risk factor for ...